Zobrazeno 1 - 10
of 94
pro vyhledávání: ''
Autor:
Yu, Wang, Tao, Zhang, Yilin, Huang, Wei, Li, Jingjing, Zhao, Yin, Yang, Canjun, Li, Luhua, Wang, Nan, Bi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:1154-1164
Consolidation durvalumab after chemoradiation therapy (CRT) has improved patient outcomes in stage III non-small cell lung cancer (NSCLC) since the practice-changing results of the PACIFIC trial, whereas real-world evidence regarding the PACIFIC regi
Autor:
Hiromitsu Iwata, Misuzu Yoshihara, Toshiyuki Toshito, Eiji Kunii, Yusuke Yamaba, Kensuke Hayashi, Yuta Shibamoto, K. Nakajima, Y. Hattori, Hiroyuki Ogino, Kenji Akita, Osamu Takakuwa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1359-1367
Purpose This study prospectively evaluated the efficacy and safety of concurrent chemo-proton therapy (CCPT) using adaptive planning for unresectable stage III non-small cell lung cancer (NSCLC). Methods and Materials The primary endpoint was overall
Autor:
W. Zhu, Jiancheng Li, Xiaolong Fu, Luhua Wang, Baolin Qu, Ligang Xing, Jinming Yu, Conghua Xie, Chun Han, Zhengfei Zhu, Guang Li, Qin Lin, Yaping Xu, Zhiyong Yuan, Bing Lu, Tingyi Xia, Shenglin Ma, Gang Wu, Ming Chen, You Lu, Jianhua Wang, Guangying Zhu
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1349-1358
Purpose This study aimed to compare erlotinib (E) and etoposide/cisplatin (EP) with concurrent radiation therapy (RT) for patients with stage IIIA/B unresectable advanced non-small cell lung cancer with activating epidermal growth factor receptor mut
Autor:
W David J Ryder, Catherine Harris, Stephen Harrow, Kate Haslett, Corinne Faivre-Finn, P. McCloskey, Matthew Hatton, Fiona McDonald, N. Bayman, Gerard G Hanna, N. Groom, Kevin Franks, Susan Harden
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Haslett, K, Bayman, N, Franks, K, Groom, N, Harden, S V, Harris, C, Hanna, G, Harrow, S, Hatton, M, McCloskey, P, McDonald, F, Ryder, W D & Faivre-Finn, C 2021, ' Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study ', International Journal of Radiation Oncology Biology Physics, vol. 109, no. 5, pp. 1341-1348 . https://doi.org/10.1016/j.ijrobp.2020.11.040
Haslett, K, Bayman, N, Franks, K, Groom, N, Harden, S V, Harris, C, Hanna, G, Harrow, S, Hatton, M, McCloskey, P, McDonald, F, Ryder, W D & Faivre-Finn, C 2021, ' Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study ', International Journal of Radiation Oncology Biology Physics, vol. 109, no. 5, pp. 1341-1348 . https://doi.org/10.1016/j.ijrobp.2020.11.040
Purpose: Not all patients with stage III non-small cell lung cancer (NSCLC) are suitable for concurrent chemoradiation therapy (CRT). Local failure rate is high for sequential concurrent CRT. As such, there is a rationale for treatment intensificatio
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:597-601
Purpose Many patients with lung cancer are inactive due to their disease and underlying comorbidities, and activity levels can decline further during cancer therapy. Here we explore dosimetric predictors of activity decline in a cohort of patients wh
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 106:985-992
Purpose The standard of care in management of patients with good performance status and unresectable stage III non-small cell lung cancer (NSCLC) therapy is concurrent chemoradiation. Newer techniques such as intensity modulated radiation therapy (IM
Autor:
Tracey E. Schefter, Moyed Miften, Edward M. Castillo, Brian D. Kavanagh, Inga S. Grills, Nicholas Myziuk, Quentin Diot, Daniel W. Bowles, Thomas Guerrero, Laurie E. Gaspar, Yevgeniy Vinogradskiy, Richard Castillo, Bernard L. Jones, Craig W. Stevens, Jennifer J. Kwak, Chad G. Rusthoven
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Studies have noted a link between radiation dose to the heart and overall survival (OS) for patients with lung cancer treated with chemoradiation. The purpose of this study was to characterize pre- to posttreatment cardiac metabolic changes u
Autor:
Laura Hughes, Nicholas Counsell, Elizabeth Miles, Yenting Ngai, Virginia Laurence, Susan Harden, David Landau, Zafar Malik, John D. Fenwick, C. Eswar, Paula Wells, William Philip M. Mayles, Laura Farrelly, Marianne Illsley, Nazia Mohammed, Andrew Bates, James Spicer, Angel Garcia-Alonso, Anne Marie Mullin, S. Vivekanandan, Angela Baker
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Purpose The IDEAL-CRT phase 1/2 multicenter trial of isotoxically dose-escalated concurrent chemoradiation for stage II/III non-small cell lung cancer investigated two 30-fraction schedules of 5 and 6 weeks’ duration. We report toxicity, tumor resp
Autor:
Araceli Garcia-Gonzalez, Qiuling Shi, Zhongxing Liao, Charles S. Cleeland, Mona Kamal, Steven H. Lin, Xin Shelley Wang, Tito R. Mendoza, Raza H Bokhari, Joe Y. Chang, H. Lin
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose In patients with non-small cell lung cancer (NSCLC), concurrent chemoradiation therapy (CRT) exacerbates a cluster of difficult-to-manage symptoms, especially cancer-related fatigue. Minocycline is a readily available, low-cost antibiotic wit
Autor:
Haiying Cheng, Chandan Guha, Shalom Kalnicki, Madhur Garg, Nitin Ohri, Balazs Halmos, William Bodner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:745-751
Here we explore the prognostic value of baseline step count data captured using wearable devices for patients treated with definitive chemoradiation therapy for locally advanced non-small cell lung cancer (NSCLC).Patients with locally advanced NSCLC